Company intelligence / Profile preview

FATRO

Ozzano dell'Emilia, Emilia-Romagna, Italyfatro.it ↗

Ownership: Private
Employees: ~700
Development stage: Commercial

Overview

FATRO is a long-established Italian veterinary pharmaceutical group that develops, manufactures and markets a wide range of ethical drugs, vaccines and feed additives for livestock and companion animals. It operates large GMP production sites in Ozzano Emilia and Maclodio, exports to over 90 countries, and has been expanding its portfolio with innovative recombinant vaccines through technology collaborations such as Algenex’s CrisBio platform.

Therapeutic areas: OtherInfectious Diseases
Modalities: Small moleculeVaccineBiologicRecombinant protein
Industry: Veterinary

Partnerships

Algenex (CrisBio-based recombinant veterinary vaccines, including rabbit viral haemorrhagic disease and swine indications)Steriline (robotic filling solution for single-dose prefilled syringe veterinary vaccines)

Beyond the preview

Go deeper on FATRO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FATRO.

Explore the full profile